The pilot programs explore wholesale settlement between institutions and real-world use cases, along with stablecoin development and tokenized bank deposits.
You might also be interested in reading Neurocrine refines INGREZZA net sales guidance to $2.5B-$2.55B while CRENESSITY surges, driving revenue growth and pipeline expansion.